Apollomics (APLMW) Competitors $0.02 +0.00 (+3.18%) As of 08/5/2025 03:43 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock APLMW vs. ATNFW, SXTPW, DRTSW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. Apollomics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, earnings, valuation, media sentiment, risk, analyst recommendations, profitability and institutional ownership. Does the media refer more to ATNFW or APLMW? In the previous week, 180 Life Sciences had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Apollomics. 180 Life Sciences' average media sentiment score of 0.95 beat Apollomics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Apollomics Neutral Which has better valuation and earnings, ATNFW or APLMW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AApollomicsN/AN/AN/AN/AN/A Is ATNFW or APLMW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Apollomics N/A N/A N/A Summary180 Life Sciences beats Apollomics on 2 of the 2 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLMW vs. The Competition Export to ExcelMetricApollomicsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$137.01M$5.59B$9.53BDividend YieldN/A3.74%4.73%4.14%P/E RatioN/A3.7528.9123.88Price / SalesN/A4,302.40448.7998.82Price / CashN/A13.1935.6858.35Price / BookN/A39.278.165.60Net IncomeN/A-$90.99M$3.25B$265.26M7 Day PerformanceN/A-0.82%1.15%-0.14%1 Month PerformanceN/A4.14%8.25%6.08%1 Year PerformanceN/A179.01%29.18%24.22% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMWApollomicsN/A$0.02+3.2%N/A+106.4%$0.00N/A0.0059Gap UpATNFW180 Life SciencesN/A$0.01+0.8%N/A+38.2%$0.00N/A0.007Gap UpHigh Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.06+21.5%N/A+143.7%$0.00$665.45K0.002Gap UpDRTSWAlpha Tau MedicalN/A$0.23-2.9%N/A+140.6%$0.00N/A0.0080Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.05-2.8%N/A-79.9%$0.00N/A0.008Positive NewsShort Interest ↑Gap UpCDIOWCardio DiagnosticsN/A$0.01-1.4%N/A-67.6%$0.00$19.90K0.007Positive NewsShort Interest ↑Gap DownCELUWCelularityN/A$0.05-16.5%N/A+143.9%$0.00$54.22M0.00220Positive NewsGap DownCEROWCERo TherapeuticsN/A$0.02-10.6%N/A-35.3%$0.00N/A0.008News CoveragePositive NewsShort Interest ↑Gap DownCINGWCingulateN/A$0.13+9.4%N/A+1,285.6%$0.00N/A0.0020Gap DownCLNNWCleneN/A$0.03-31.1%N/A+30.0%$0.00$350K0.00100Gap DownCOEPWCoeptis TherapeuticsN/A$0.02-15.0%N/A+24.9%$0.00$62.87K0.004Positive News Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLMW) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
